FDA already has set up a Center for Oncology Excellence and there's now interest in creating a Center for Neuroscience Excellence.
One interested party is Lundbeck, a biopharma focused on neurologic drugs - products here.
See Lundbeck's webpage about why a "Center for Neuroscience" at FDA is a good idea - here.
The Senate press release about the bill is here. Note, a link to "text of the bill" at that webpage was not active for me today. However, I found the full text of the legislation online at S.3427 here.